Prosecution Insights
Last updated: April 19, 2026
Application No. 17/527,101

ISOCYANURATE RESIN COMPOSITIONS

Non-Final OA §102§103§112
Filed
Nov 15, 2021
Examiner
WHITELEY, JESSICA
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Divergent Technologies Inc.
OA Round
7 (Non-Final)
88%
Grant Probability
Favorable
7-8
OA Rounds
2y 1m
To Grant
96%
With Interview

Examiner Intelligence

Grants 88% — above average
88%
Career Allow Rate
1317 granted / 1489 resolved
+23.4% vs TC avg
Moderate +7% lift
Without
With
+7.1%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
47 currently pending
Career history
1536
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
31.5%
-8.5% vs TC avg
§102
34.8%
-5.2% vs TC avg
§112
16.6%
-23.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1489 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the application Receipt of Applicant’s request for continued examination filed on January 16, 2026 is acknowledged. A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on January 16, 2026 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 1 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 2-9 and 32-41 depend on claim 1 and, therefore are also rejected. With regards to claim 1, the claim states that the isocyanurate or cyanurate component are bonded to an acrylate or methacrylate component via an R group, however, the R group is not further defined. For the purposes of compact resolution, the R group will be determined to read on any group including a single bond. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-98 and 32-41 are rejected under 35 U.S.C. 103 as being unpatentable over Eckel et al (WO 2018/08704) which references Boettcher et al (US 4,652,274). With regards to claims 1, 8, and 33, Eckel teaches a composition containing organic binders that are cured by radiation (pages 7 and 8) that includes isocyanurate resins (page 9) isocyanurate derivatives as described in Boettcher (page 11). Boettcher teaches isocyanurate derivatives having the following structure: PNG media_image1.png 80 90 media_image1.png Greyscale (column 3) wherein PNG media_image2.png 499 255 media_image2.png Greyscale (column 3). Eckel further teaches the addition of a photoinitiator (applicant cites electromagnetic radiation to include UV radiation and a photoinitiator is a compound that cures the composition when exposed to UV radiation, therefore, the photoinitiator reads on the electromagnetic radiation initiator) (page 12) and filler abrasive particles (page 2). Eckel teaches the composition to be solidified using ultraviolet light wherein the composition is converted into a solid (page 9) reading on the composition being cured in the post-cured state. Eckel does not teach the amount of the acrylated component to be greater than 90 percent by weight of the resin composition. However, generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by prior art unless there is evidence indicating such concentration or temperature is critical. See MPEP 2144.05. Further, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the concentration of the acrylate component in order to achieve the desired reactivity and viscosity of the composition. With regards to claims 2 and 4-5, Eckel teaches polymerization to occur using ultraviolet light (page 9). With regards to claim 3, Eckel teaches the addition of a photoinitiator (page 12). With regards to claims 6 and 7, Eckel teaches the addition of a photoinitiator (page 12) which are known in the art to bind the acrylate compounds of the resin composition. With regards to claim 9, Eckel teaches the addition of filler particles (page 18). With regards to claim 32, Eckel teaches the radiation to include visible light (page 9). With regards to claim 34, Eckel does not teach the viscosity of the composition. However, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the viscosity in order to achieve the desired workability prior to curing. Eckel further teaches that the viscosity is such as to allow the particles to have dwell time in the magnetic field prior to curing. With regards to claims 35-41, Eckel teaches the compound to include isocyanurate resins containing (meth)acrylate groups (page 11). Claims 1-9 and 32-41 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by An et al (WO 2015102149). With regards to claims 1-6, 8, and 32-41, An teaches a resin composition containing a binder, n acrylic monomer and an initiator (abstract). An teaches the acrylic monomer to include tris(2-hydroxyethyl)isocyanurate trimethacrylate (12). An teaches the composition to be cured using UV radiation (17-19). An teaches the composition to further include a silicone compound having the following formula: PNG media_image3.png 115 171 media_image3.png Greyscale (page 2) wherein PNG media_image4.png 101 468 media_image4.png Greyscale (page 2) and preferably R1 to R3 are methyl groups, R4 is a phenyl group, and R5 to R6 are vinyl groups (page 8 example 1), therefore, reading on the optional reactive monomer component. An teaches the composition to be cured using UV radiation (reading on a post-cured state) (page 3). An does not teach the amount of the isocyanurate compound. However, generally, differences in concentration or temperature will not support the patentability of subject matter encompassed by prior art unless there is evidence indicating such concentration or temperature is critical. See MPEP 2144.05. Further, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the concentration of the acrylate component in order to achieve the desired reactivity and viscosity of the composition. With regards to claim 7, An teaches the addition of epoxy binders or acrylates (abstracts). With regards to claim 9, An teaches the composition to include additional acrylate monomers (49-50 example 1). With regards to claim 34, An does not teach the viscosity of the composition. However, where the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation. In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 124 (CCPA 1955). In this case, one skilled in the art prior to the effective filing date of the present invention would know to alter the viscosity in order to achieve the desired workability prior to curing. Response to Arguments Applicant’s arguments, see page 10, filed January 16, 2026, with respect to the rejection(s) of claim(s) 1-9 and 31-32 under 35 USC 102 with respect to Eckel and An have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of routine experimentation. Applicant's arguments filed January 16, 2026 have been fully considered but they are not persuasive. Argument - Applicant argues that Eckel and An do not teach an acrylated component comprising an isocyanurate or a cyanurate component bonded to an acrylate or a methacrylate component via an R group. Response - As stated above, both of the art teach an isocyanurate compound having acrylate groups bound to them. It is important to note that the composition is now much more broad as the R group is not defined in the claims and the excluded compound now can be present in the art. Therefore, this argument is not persuasive Argument - Applicant argues that Eckel and An do not teach the addition of an electromagnetic radiation initiator. Response - Applicants cite in the specification and dependent claims that electromagnetic radiation includes UV or visible light radiation. Both of the references teach the addition of a photoinitiator (as stated above) and, therefore, read on an electromagnetic radiation initiator. Argument - Applicant argues that Eckel and An do not teach the resin to have both a pre-cured and post-cured state. Response - Both of the references, as stated above, teach the composition to be cured using radiation. It is important to note that the broadest reasonable interpretation of the claim reads that the pre-cured and post cured state of the composition can both be solid or liquid. Therefore, because both of the art teach the composition to be cured, they both have a pre and post-cured state. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA WHITELEY whose telephone number is (571)272-5203. The examiner can normally be reached 8 - 5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached at 5712721130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA WHITELEY/Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Nov 15, 2021
Application Filed
Dec 01, 2023
Non-Final Rejection — §102, §103, §112
Jun 06, 2024
Response Filed
Jul 03, 2024
Final Rejection — §102, §103, §112
Sep 09, 2024
Response after Non-Final Action
Sep 12, 2024
Response after Non-Final Action
Oct 07, 2024
Request for Continued Examination
Oct 08, 2024
Response after Non-Final Action
Oct 24, 2024
Non-Final Rejection — §102, §103, §112
Feb 25, 2025
Response Filed
Mar 11, 2025
Final Rejection — §102, §103, §112
May 12, 2025
Response after Non-Final Action
Jun 17, 2025
Request for Continued Examination
Jun 24, 2025
Response after Non-Final Action
Jul 07, 2025
Non-Final Rejection — §102, §103, §112
Oct 08, 2025
Response Filed
Oct 20, 2025
Final Rejection — §102, §103, §112
Jan 16, 2026
Request for Continued Examination
Jan 25, 2026
Response after Non-Final Action
Feb 03, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600808
CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELS
2y 5m to grant Granted Apr 14, 2026
Patent 12600888
DUAL-CURABLE ADHESIVE COMPOSITION
2y 5m to grant Granted Apr 14, 2026
Patent 12590264
PROFRAGRANCE CONJUGATES
2y 5m to grant Granted Mar 31, 2026
Patent 12590265
1-NORBORNAN-2-YLPROPAN-2-ONE AS A FRAGRANCE
2y 5m to grant Granted Mar 31, 2026
Patent 12583833
Enrichment of a Diastereomer in Magnolan
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
88%
Grant Probability
96%
With Interview (+7.1%)
2y 1m
Median Time to Grant
High
PTA Risk
Based on 1489 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month